Neurological Surgery, University of Miami Miller School of Medicine, Miami, Florida, USA.
Department of Neurological Surgery, University of Miami School of Medicine, Miami, Florida, USA.
J Neurointerv Surg. 2021 Jan;13(1):91-95. doi: 10.1136/neurintsurg-2020-015992. Epub 2020 Jun 2.
Currently, there are no large-scale studies in the neurointerventional literature comparing safety between transradial (TRA) and transfemoral (TFA) approaches for flow diversion procedures. This study aims to assess complication rates in a large multicenter registry for TRA versus TFA flow diversion.
We retrospectively analyzed flow diversion cases for cerebral aneurysms from 14 institutions from 2010 to 2019. Pooled analysis of proportions was calculated using weighted analysis with 95% CI to account for results from multiple centers. Access site complication rate and overall complication rate were compared between the two approaches.
A total of 2,285 patients who underwent flow diversion were analyzed, with 134 (5.86%) treated with TRA and 2151 (94.14%) via TFA. The two groups shared similar patient and aneurysm characteristics. Crossover from TRA to TFA was documented in 12 (8.63%) patients. There were no access site complications in the TRA group. There was a significantly higher access site complication rate in the TFA cohort as compared with TRA (2.48%, 95% CI 2.40% to 2.57%, vs 0%; p=0.039). One death resulted from a femoral access site complication. The overall complications rate was also higher in the TFA group (9.02%, 95% CI 8.15% to 9.89%) compared with the TRA group (3.73%, 95% CI 3.13% to 4.28%; p=0.035).
TRA may be a safer approach for flow diversion to treat cerebral aneurysms at a wide range of locations. Both access site complication rate and overall complication rate were lower for TRA flow diversion compared with TFA in this large series.
目前,神经介入文献中尚无大规模研究比较经桡动脉(TRA)和经股动脉(TFA)入路在血流导向装置中的安全性。本研究旨在评估大型多中心 TRA 与 TFA 血流导向装置的并发症发生率。
我们回顾性分析了 2010 年至 2019 年 14 家机构的脑动脉瘤血流导向装置病例。使用加权分析计算合并比例,并使用 95%可信区间进行加权分析,以考虑来自多个中心的结果。比较两种方法的入路并发症发生率和总并发症发生率。
共分析了 2285 例接受血流导向装置治疗的患者,其中 134 例(5.86%)采用 TRA 治疗,2151 例(94.14%)采用 TFA 治疗。两组患者的一般资料和动脉瘤特征相似。12 例(8.63%)患者从 TRA 转为 TFA。TRA 组无入路并发症。TFA 组的入路并发症发生率明显高于 TRA 组(2.48%,95%可信区间 2.40%至 2.57%,与 0%相比;p=0.039)。1 例死亡与股动脉入路并发症有关。TFA 组的总并发症发生率也高于 TRA 组(9.02%,95%可信区间 8.15%至 9.89%),TRA 组为 3.73%(95%可信区间 3.13%至 4.28%;p=0.035)。
TRA 可能是治疗广泛部位脑动脉瘤的更安全方法。在这项大型系列研究中,TRA 血流导向装置的入路并发症发生率和总并发症发生率均低于 TFA。